DV BIOMED CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.5 TWD | -2.20% |
|
-1.11% | -9.46% |
| 04-11 | DV Biomed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | DV Biomed Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| Sales 2022 | 1.87B 57.44M 78.42M | Sales 2023 | 1.54B 47.22M 64.47M | Capitalization | 2.91B 89.45M 122M |
|---|---|---|---|---|---|
| Net income 2022 | 281M 8.63M 11.78M | Net income 2023 | 163M 5M 6.83M | EV / Sales 2022 | 1.69 x |
| Net cash position 2022 | 119M 3.64M 4.97M | Net Debt 2023 | 111M 3.41M 4.66M | EV / Sales 2023 | 1.97 x |
| P/E ratio 2022 |
11.8
x | P/E ratio 2023 |
18
x | Employees | 326 |
| Yield 2022 |
9.64% | Yield 2023 |
-
| Free-Float | 98.09% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.20% | ||
| 1 week | -1.11% | ||
| Current month | +1.14% | ||
| 1 month | +3.49% | ||
| 3 months | -10.82% | ||
| 6 months | -14.59% | ||
| Current year | -9.46% |
1 week
44.00
45.50
1 month
42.6046.00
Current year
42.4054.70
1 year
42.4071.00
3 years
42.4071.00
5 years
21.9274.00
10 years
21.92136.71
| Managers | Title | Age | Since |
|---|---|---|---|
Chia Chu Tsai
CEO | Chief Executive Officer | - | 11-06-20 |
Hsiu Mei Hsieh
DFI | Director of Finance/CFO | - | - |
Hui Chuan Chen
AUD | Comptroller/Controller/Auditor | - | 14-02-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jen Cheng Hsieh
BRD | Director/Board Member | - | 15-07-09 |
Chia Chu Tsai
CEO | Chief Executive Officer | - | 11-06-20 |
Chia Chi Chang
BRD | Director/Board Member | - | 13-12-08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 44.5 | -2.20% | 1 |
| 24-04-25 | 45.5 | +2.25% | 3,166 |
| 24-04-24 | 44.5 | 0.00% | 24,305 |
| 24-04-23 | 44.5 | -1.11% | 46,000 |
| 24-04-19 | 45 | -1.53% | 12,427 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes
Dv Biomed Co Ltd is a Taiwan-based company mainly engaged in the sale of health food products, medical-grade maintenance products and medical consumables, as well as the provision of beauty and body care services. The medical consumables include medical beauty equipment, instrument probes, injections and implantable fillers. The Company is also engaged in the rental of medical beauty equipment. The medical-grade maintenance products and medical consumables are mainly used in medical beauty related industries. The Company is also engaged in the beauty skin care business and stem cell new drug development business. The Company distributes products within domestic market and to overseas markets.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.46% | 81.56M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- 6539 Stock
